If you need more lookups,
subscriptions start at $34 USD/month.
Erin Henitz Location
New York, NY, US
Erin Henitz Work
VP, Global Head of Translational and Quantitative Science Data Mgmt and Clinical Biomarker Operations @ (February 2024 - Present)
Senior Director, Global Head of Precision Medicine Operations and Diagnostics @ (January 2022 - February 2024)
Senior Director, Head of Biomarker Operations and Trial Management, Solid Tumor @ (January 2021 - January 2022)
Director, Team Lead, Biomarker Operations and Trial Management @ (January 2020 - January 2021)
Director, Biomarker Operations @ (June 2018 - January 2020)
Director, Oncology Translational Research Operations Lead @ (March 2017 - May 2018)
Associate Director, Oncology Translational Research @ (March 2015 - March 2017)
Manager, Oncology Biomarker Operations @ (January 2005 - March 2015)
Sample Bank Coordinator @ (January 2002 - January 2005)
Erin Henitz Education
University of Maryland University College
Masters of Science (Biotechnology Management)
2011-2013
Richard Stockton College of New Jersey
Bachelor of Science (Biology)
1999-2003
Erin Henitz Skills
Oncology
Biomarkers
Clinical Research
Clinical Trials
Clinical Development
CRO
Biotechnology
CTMS
Pharmaceutical Industry
GCP
Molecular Biology
Drug Development
FDA
Clinical Operations
Medical Devices
Cancer
Public Speaking
Sales
Microsoft Word
Microsoft Office
Erin Henitz Summary
Erin Henitz, based in New York, NY, US, is currently a VP, Global Head of Translational and Quantitative Science Data Mgmt and Clinical Biomarker Operations at Genmab. Erin Henitz brings experience from previous roles at Genmab. Erin Henitz holds a 2011 - 2013 Masters of Science in Biotechnology Management @ University of Maryland University College. With a robust skill set that includes Oncology, Biomarkers, Clinical Research, Clinical Trials, Clinical Development and more. Erin Henitz has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Erin Henitz?
Find contact details for 700 million professionals.